SCRI

SCRI Impact Report 2023

Issue link: https://uberflip.scri.com/i/1521059

Contents of this Issue

Navigation

Page 8 of 27

Where the Science of Collaboration Leads to Research Innovation SCRI is the only oncology research organization of its kind to offer end-to-end clinical trial site management, contract research services for biopharma, and personalized medicine advisory services in one place: SCRI's Site Management Organization (SMO) delivers operational, regulatory and other centralized research support services for industry- sponsored and investigator-initiated trials. SCRI Development Innovations, a global, full-service contract research organization (CRO) works in concert with SCRI's SMO, specializing in oncology clinical development services from first- in-human studies to regulatory approval. Genospace, a fully integrated precision medicine technology, powers SCRI's clinical trial offerings by ensuring we match the right therapy to the right patient at the right time.

Articles in this issue

view archives of SCRI - SCRI Impact Report 2023